Beacon Investment Advisory Services’s Inspire Medical Systems INSP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-2,062
Closed -$382K 245
2024
Q4
$382K Sell
2,062
-5,910
-74% -$1.15M 0.02% 192
2024
Q3
$1.68M Sell
7,972
-603
-7% -$105K 0.07% 123
2024
Q2
$1.15M Sell
8,575
-172
-2% -$32.5K 0.05% 130
2024
Q1
$1.88M Buy
8,747
+254
+3% +$49.8K 0.08% 119
2023
Q4
$1.73M Sell
8,493
-652
-7% -$106K 0.08% 122
2023
Q3
$1.81M Buy
9,145
+8,429
+1,177% +$2.13M 0.09% 122
2023
Q2
$232K Buy
+716
New +$205K 0.01% 258
2023
Q1
Sell
-849
Closed -$214K 284
2022
Q4
$214K Buy
+849
New +$181K 0.01% 261
2022
Q2
Sell
-911
Closed -$234K 296
2022
Q1
$234K Buy
+911
New +$208K 0.01% 277

Other funds holding INSP

Beacon Investment Advisory Services's INSP Position: Q1 2025 in Review

Beacon Investment Advisory Services sold out of Inspire Medical Systems (INSP) in Q1 2025, closing a stake of 2,062 shares — an estimated $382K sold.

Beacon Investment Advisory Services first reported a position in INSP in Q1 2022 and held it in 9 quarters. The position peaked at $1.88M in Q1 2024. 363 funds tracked by Wall St. Rank hold INSP as of Q1 2025.

  • Beacon Investment Advisory Services reported no remaining Inspire Medical Systems position as of Q1 2025 after selling out during the quarter.
  • Beacon Investment Advisory Services sold 2,062 Inspire Medical Systems shares in Q1 2025, an estimated $382K.
  • Beacon Investment Advisory Services first reported a position in Inspire Medical Systems in Q1 2022 and held it in 9 quarters.
  • Beacon Investment Advisory Services's Inspire Medical Systems position peaked at $1.88M in Q1 2024.
  • 363 funds tracked by Wall St. Rank held Inspire Medical Systems as of Q1 2025.

Based on Beacon Investment Advisory Services's 13F filing for Q1 2025, filed 6 May 2025.